A defined role
The FDA classification refers to debridement of non-healing necrotic skin and soft-tissue wounds, including pressure, venous stasis and neuropathic foot ulcers, and selected traumatic or postsurgical wounds. A category description is not a recommendation for every wound in that category. FDA classification
The wound label is not enough
Two people with the same general wound label can have different care needs. The relevant question is why a particular method is appropriate for a particular person, not whether a website lists the condition.
Compare goals and alternatives
Ask what tissue needs to be removed, what the care team hopes to achieve and which alternatives are available. A treatment may be used as one part of a wider plan rather than as a replacement for other necessary care.
Use evidence carefully
Reviews of chronic leg and foot ulcers can help frame the discussion, but findings are not interchangeable across all wound types. Our research library identifies the study type so readers can follow the evidence rather than a blanket claim. Review of trials
A safe next step
Arrange a clinical assessment. This site does not determine wound stage, infection status or eligibility for treatment.
Sources & further reading
Follow the original source for complete details and subsequent updates.